Bayer Appoints New Head of R&D at Pharmaceuticals
27 Oktober 2020 - 2:46PM
Dow Jones News
By Giulia Petroni
Bayer AG said Tuesday that it appointed Christian Rommel as the
new head of research and development at its pharmaceuticals
division, effective from Feb. 1.
The German pharmaceutical and chemical conglomerate said Mr.
Rommel will succeed Joerg Moeller, who decided to leave the company
effective Dec. 31 to pursue other career opportunities.
Mr. Rommel will serve on the pharmaceuticals executive committee
and report to Stefan Oelrich, the division's president and a member
of the board of management.
Prior to joining Bayer, Mr. Rommel served as senior vice
president and global head of oncology research and early
development at Hoffmann-La Roche AG.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
October 27, 2020 09:31 ET (13:31 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Bayer (TG:BAYN)
Historical Stock Chart
Von Apr 2023 bis Apr 2024